{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:02:04Z","timestamp":1747368124121,"version":"3.40.5"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["fertstertscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Science"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.xfss.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:40:21Z","timestamp":1740156021000},"page":"164-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prioritization of potential drug targets in ovarian-related diseases: Mendelian randomization and colocalization analyses"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4507-0093","authenticated-orcid":false,"given":"Yanggang","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfss.2025.02.003_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/humupd\/2.5.435","article-title":"Diagnosis and management of organic ovarian cysts: indications and procedures for laparoscopy","volume":"2","author":"Chapron","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2025.02.003_bib2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.xfss.2025.02.003_bib3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrendo.2017.36","article-title":"Environmental influences on ovarian dysgenesis \u2013 developmental windows sensitive to chemical exposures","volume":"13","author":"Johansson","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.xfss.2025.02.003_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.xfss.2025.02.003_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/humupd\/dmv012","article-title":"Risks of conservative management in women with ovarian endometriomas undergoing IVF","volume":"21","author":"Somigliana","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2025.02.003_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/annonc\/mds514","article-title":"Female fertility loss and preservation: threats and opportunities","volume":"24","author":"Salama","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.xfss.2025.02.003_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/humupd\/dmv044","article-title":"Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome","volume":"22","author":"Vannuccini","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2025.02.003_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.fertnstert.2012.06.029","article-title":"Pathogenesis and pathophysiology of endometriosis","volume":"98","author":"Burney","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfss.2025.02.003_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ogc.2012.10.002","article-title":"Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility","volume":"39","author":"Macer","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.xfss.2025.02.003_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(10)60490-4","article-title":"Endometriosis and infertility: pathophysiology and management","volume":"376","author":"de Ziegler","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.xfss.2025.02.003_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2018.12.015","article-title":"Endometriosis and cancer","volume":"133","author":"Kajiyama","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.xfss.2025.02.003_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2005.11.033","article-title":"Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence","volume":"101","author":"Somigliana","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.xfss.2025.02.003_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.xfss.2025.02.003_bib14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00003081-200609000-00010","article-title":"The incidental postmenopausal adnexal mass","volume":"49","author":"McDonald","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.xfss.2025.02.003_bib15","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1097\/JS9.0000000000001814","article-title":"The role of immune cell signatures in the pathogenesis of ovarian-related diseases: a causal inference based on Mendelian randomization","volume":"110","author":"Lu","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.xfss.2025.02.003_bib16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/ijms23010512","article-title":"Estradiol signaling at the heart of folliculogenesis: its potential deregulation in human ovarian pathologies","volume":"23","author":"Chauvin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xfss.2025.02.003_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148678","article-title":"Role of ERbeta in the ovary and ovary related diseases","volume":"927","author":"Bao","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.xfss.2025.02.003_bib18","first-page":"5087","article-title":"New insights into mTOR signal pathways in ovarian-related diseases: polycystic ovary syndrome and ovarian cancer","volume":"17","author":"Liu","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.xfss.2025.02.003_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/humupd\/dmx019","article-title":"Baseline anatomical assessment of the uterus and ovaries in infertile women: a systematic review of the evidence on which assessment methods are the safest and most effective in terms of improving fertility outcomes","volume":"23","author":"Armstrong","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2025.02.003_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/6.5.505","article-title":"Direct ovarian effects and safety aspects of GnRH agonists and antagonists","volume":"6","author":"Janssens","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2025.02.003_bib21","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1007\/s10815-024-03251-1","article-title":"Unlocking the potential of artificial intelligence in reproductive medicine: a bibliometric analysis from 1999 to 2024","volume":"41","author":"Wang","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AOG.0000000000002469","article-title":"Clinical management of endometriosis","volume":"131","author":"Falcone","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xfss.2025.02.003_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-animal-021419-084010","article-title":"Implications of assisted reproductive technologies for pregnancy outcomes in mammals","volume":"8","author":"Hansen","year":"2020","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.xfss.2025.02.003_bib24","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/eurheartj\/ehv145","article-title":"Cardiovascular dysfunction in children conceived by assisted reproductive technologies","volume":"36","author":"Scherrer","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.xfss.2025.02.003_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jwh.2014.5000","article-title":"Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study","volume":"24","author":"Joham","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.xfss.2025.02.003_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.xfss.2025.02.003_bib27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd4051","article-title":"Validating therapeutic targets through human genetics","volume":"12","author":"Plenge","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.xfss.2025.02.003_bib29","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xfss.2025.02.003_bib30","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1007\/s10815-024-03295-3","article-title":"No direct association between male infertility and multiple sclerosis: evidence from Mendelian randomization analysis","volume":"41","author":"Shu","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","article-title":"Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19","volume":"27","author":"Gaziano","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.xfss.2025.02.003_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jad.2024.11.002","article-title":"Deciphering the genetic underpinnings of neuroticism: a Mendelian randomization study of druggable gene targets","volume":"370","author":"Hong","year":"2025","journal-title":"J Affect Disord"},{"key":"10.1016\/j.xfss.2025.02.003_bib33","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.xfss.2025.02.003_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib35","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.xfss.2025.02.003_bib36","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.xfss.2025.02.003_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xfss.2025.02.003_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.xfss.2025.02.003_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/aji.70036","article-title":"Causal relationship between antibody-mediated immune responses of Chlamydia trachomatis infection and reproductive tract complications: a bidirectional Mendelian randomization study","volume":"93","author":"Hong","year":"2025","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.xfss.2025.02.003_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009922","article-title":"Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model","volume":"17","author":"Lin","year":"2021","journal-title":"PLOS Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib42","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/sim.6522","article-title":"Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome","volume":"34","author":"Greco","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.xfss.2025.02.003_bib43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.xfss.2025.02.003_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLOS Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","article-title":"Rare variant contribution to human disease in 281,104 UK biobank exomes","volume":"597","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xfss.2025.02.003_bib46","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib47","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.xfss.2025.02.003_bib48","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.3390\/ijms25094802","article-title":"Immune dysregulation in endometriomas: implications for inflammation","volume":"25","author":"Dymanowska-Dyjak","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xfss.2025.02.003_bib49","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s12325-020-01363-5","article-title":"Malignant transformation and associated biomarkers of ovarian endometriosis: a narrative review","volume":"37","author":"Mikhaleva","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.xfss.2025.02.003_bib50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41467-019-13984-8","article-title":"Cold-induced urticarial autoinflammatory syndrome related to factor XII activation","volume":"11","author":"Scheffel","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.xfss.2025.02.003_bib51","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1158\/2159-8290.CD-20-1213","article-title":"Selective modulation of a pan-essential protein as a therapeutic strategy in cancer","volume":"11","author":"Malone","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.xfss.2025.02.003_bib52","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.7150\/thno.94943","article-title":"Mesenchymal stem cell-derived apoptotic vesicles ameliorate impaired ovarian folliculogenesis in polycystic ovary syndrome and ovarian aging by targeting WNT signaling","volume":"14","author":"Fu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.xfss.2025.02.003_bib53","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1158\/0008-5472.CAN-21-1807","article-title":"Autocrine canonical Wnt signaling primes noncanonical signaling through ROR1 in metastatic castration-resistant prostate cancer","volume":"82","author":"Ma","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.xfss.2025.02.003_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106660","article-title":"Exosomal miR-211-5p regulates glucose metabolism, pyroptosis, and immune microenvironment of melanoma through GNA15","volume":"188","author":"Zeng","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.xfss.2025.02.003_bib55","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41467-022-31248-w","article-title":"Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance","volume":"13","author":"Xia","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.xfss.2025.02.003_bib56","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1002\/tox.24259","article-title":"PTPN7 mediates macrophage-polarization and determines immunotherapy in gliomas: a single-cell sequencing analysis","volume":"39","author":"Ji","year":"2024","journal-title":"Environ Toxicol"},{"issue":"1456\u201362","key":"10.1016\/j.xfss.2025.02.003_bib57","first-page":"e1","article-title":"Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor","volume":"36","author":"Menges","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.xfss.2025.02.003_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011289","article-title":"The role of emerin in cancer progression and metastasis","volume":"22","author":"Liddane","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xfss.2025.02.003_bib59","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1158\/0008-5472.CAN-12-3337","article-title":"Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis","volume":"73","author":"Hoshiko","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.xfss.2025.02.003_bib60","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12935-023-03019-0","article-title":"Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT\/mTOR signaling pathway","volume":"23","author":"Di","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.xfss.2025.02.003_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.166","article-title":"T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma","volume":"50","author":"Yang","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.xfss.2025.02.003_bib62","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1038\/s41388-021-01998-w","article-title":"Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1\/Nme2-deficient mice reveals novel markers of survival in human patients","volume":"40","author":"Leonard","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.xfss.2025.02.003_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12935-020-01323-7","article-title":"Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer","volume":"20","author":"Sun","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.xfss.2025.02.003_bib64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature12785","article-title":"HMGA2 functions as a competing endogenous RNA to promote lung cancer progression","volume":"505","author":"Kumar","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xfss.2025.02.003_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.140747","article-title":"Trifloxystrobin induced developmental toxicity by disturbing the ABC transporters, carbohydrate and lipid metabolism in adult zebrafish","volume":"349","author":"Chen","year":"2024","journal-title":"Chemosphere"},{"key":"10.1016\/j.xfss.2025.02.003_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2005.12.007","article-title":"Balancing cell adhesion and Wnt signaling, the key role of beta-catenin","volume":"16","author":"Brembeck","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.xfss.2025.02.003_bib67","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xfss.2025.02.003_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.xfss.2025.02.003_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-019-0942-1","article-title":"Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt\/\u03b2-catenin signaling pathway","volume":"18","author":"Wang","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.xfss.2025.02.003_bib70","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xfss.2025.02.003_bib71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.xfss.2025.02.003_bib72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tips.2006.08.005","article-title":"MAPK-specific tyrosine phosphatases: new targets for drug discovery?","volume":"27","author":"Barr","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.xfss.2025.02.003_bib73","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41420-022-01221-z","article-title":"Extracellular vesicles microRNA-592 of melanoma stem cells promotes metastasis through activation of MAPK\/ERK signaling pathway by targeting PTPN7 in non-stemness melanoma cells","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.xfss.2025.02.003_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.126595","article-title":"ABCG1 and ABCG4 as key transporters in the development of pulmonary alveolar proteinosis by nanoparticles","volume":"420","author":"Jeon","year":"2021","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.xfss.2025.02.003_bib75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJMoa2117872","article-title":"Germline mutations in CIDEB and protection against liver disease","volume":"387","author":"Verweij","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xfss.2025.02.003_bib76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/humupd\/dmi012","article-title":"Premature ovarian failure","volume":"11","author":"Goswami","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfss.2025.02.003_bib77","article-title":"Premature ovarian insufficiency","volume":"384","author":"Nash","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.xfss.2025.02.003_bib78","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2020.12.010","article-title":"Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4(-\/-) mouse model of PFIC3","volume":"74","author":"Wei","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.xfss.2025.02.003_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoab012","article-title":"Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model","volume":"2021","author":"Zakerkish","year":"2021","journal-title":"Hum Reprod Open"}],"container-title":["F&S Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X25000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666335X25000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:29:20Z","timestamp":1747286960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666335X25000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2666335X25000175"],"URL":"https:\/\/doi.org\/10.1016\/j.xfss.2025.02.003","relation":{},"ISSN":["2666-335X"],"issn-type":[{"type":"print","value":"2666-335X"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prioritization of potential drug targets in ovarian-related diseases: Mendelian randomization and colocalization analyses","name":"articletitle","label":"Article Title"},{"value":"F&S Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfss.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}